Healthtech Startups

DC Klinieken operates 17 specialized outpatient clinics across the Netherlands, providing medical care such as gastroenterology, radiology, and women's health with referral from a general practitioner. Its roughly 900 healthcare professionals treat about 175,000 patients per year, with care generally reimbursed by Dutch health insurers.

1 investor

dClinic develops blockchain, machine learning and AI-based enterprise health platforms and clinical information systems for healthcare organisations, with projects delivered for Australian healthcare providers. The company also runs a VIC Rewards partner program and operates across Australia and Southeast Asia.

1 investor

Duoseq offers a comprehensive cancer genomics assay that profiles both DNA and RNA from a single sample in one preparation, delivering mutations, expression, fusions, and clonotype data with sample-to-report turnaround in about two days. It is built for on-site lab use with robotic workflow automation and integrates directly with EPIC and other EHR systems.

1 investor

DDS Lab is a dental laboratory providing custom ceramics, dentures, partials, nightguards, and sleep apnea devices for dental offices. The company offers case tracking and customer portal services to support real-time collaboration between the lab and dental practices.

1 investor

Company led by Sidney Collin (CEO/Founder) featured as a Wai-Mohala portfolio partner.

1 investor

Deaf AI develops artificial intelligence that produces sign language, including digital human interpreters that translate real-time speech into sign language, to make public services, media, online meetings, games, and virtual environments accessible to deaf people. It helps service providers, organizations, and businesses communicate with deaf users in sign language on demand.

1 investor

DealForma provides a data platform and analyst support for biopharma business development teams to research partnerships, deals, funding trends, and therapeutic areas. The service combines curated company profiles from thousands of industry sources with direct analyst assistance for deal preparation and strategic research.

1 investor

Dear Doc provides birth control access and reproductive health services for women in Singapore, delivered online in a discreet and judgment-free manner. The platform aims to make contraception affordable and accessible on women's own terms.

1 investor

DEBN develops drug-eluting biopsy needles that deliver antibiotics directly to the prostate during transrectal ultrasound-guided biopsy procedures, reducing post-procedure infectious complications. The medical device targets urologists and healthcare systems performing prostate cancer diagnosis.

1 investor

DECA Dental is a dental services organization that partners with dentists and their teams by providing operational support, education, and collaboration across its dental offices. It serves both patients seeking dental care and dentists looking for a growth partner.

1 investor

Regeneron is a biopharmaceutical company that discovers, develops, and commercializes medicines using proprietary technologies and genetic databases. The company serves patients with serious diseases across oncology, immunology, ophthalmology, and other therapeutic areas.

1 investor

Decipher is a healthcare navigation service that helps individuals understand and access their health benefits without incurring large costs. It positions itself as an affordable alternative to expensive navigation services for consumers.

1 investor

DecisionRx is a health technology company focused on medication decision support and pharmacy operations within the diagnostics and pharmacogenomics space. Its leadership brings experience from diagnostics labs, health insurers, and healthcare technology firms.

1 investor

Decorum Medical develops the AutoTrach, a tracheostomy tube system that rinses, cleans, and evacuates airway secretions at the press of a button to reduce obstruction and infection risk. It serves tracheostomy and advanced airway care patients and healthcare workers in the medical device industry.

1 investor

1 investor

Deep Centered Mental Health is Texas's leading provider of outpatient mental health services, offering therapy and psychiatry through both in-person and telehealth modalities. The practice employs top-tier psychiatrists and therapists who deliver evidence-based, patient-centered care to insured clients throughout the state.

1 investor

Deep Meditate is a mobile app offering meditation, music, and sleep programs designed to reduce stress and build mental resilience. The app targets individuals seeking stress relief and improved sleep quality.

1 investor

DeepHealth is an AI-powered health informatics company that develops clinical AI solutions for imaging analysis in breast, chest, neuro, prostate, and thyroid health. The company, a subsidiary of RadNet Inc., serves healthcare providers and diagnostic imaging centers globally.

1 investor

DeepIntent is a healthcare demand-side platform that combines media, identity, and clinical data to enable pharmaceutical companies and healthcare marketers to deliver privacy-safe, omnichannel advertising campaigns with measurable patient outcomes.

1 investor

1 investor

DeepSport provides performance measurement, analysis, and reporting technology for sports athletes, coaches, and researchers. The platform serves professional sports clubs, schools, fitness centers, and research institutions across various levels of athletic training and evaluation.

1 investor

Deffai is an AI-native regulatory affairs platform that helps life sciences companies prepare and strengthen FDA submissions using domain-specific AI built on review patterns and guidances. It targets biotech and medical device firms working on areas such as cell and gene therapy, vaccines, oncology, and combination products, and is staffed by former FDA reviewers and decision-makers.

1 investor

Defined Bioscience develops cell culture media, growth factors, and related reagents for stem cell biology and regenerative medicine research. The company supplies branded products for laboratory and research use.

1 investor

Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.

1 investor